(1 - 8 from 14
)
BioWa and Medarex Announce License of BioWa's C...
www.investegate.co.uk
16 Jul — ... with Medarex, who is also our first partner for POTELLIGENT(R) Technology," commented Dr. Masamichi Koike, President and CEO of BioWa. › biowa--inc. › prn › bio...
NEWS RELEASE - Kyowa Kirin
www.kyowakirin.com
Masamichi Koike, Ph.D. President and CEO. Phone: + BIOWA ANNOUNCES LICENSE OF POTELLIGENT® TECHNOLOGY TO. MERCK KGAA. › news_releases › pdf
Agensys Taps BioWa Technology for Cancer Antibody ...
www.genengnews.com
15 Nov — ... in solid tumors will greatly extend the benefits of the Potelligent Technology,” says Masamichi Koike, Ph.D., BioWa's president and CEO. › topics › drug-discovery
BioWa Licenses POTELLIGENT® Technology to GSK for Use ...
www.technologynetworks.com
9 Dec — "GSK is recognized as a key player in the field of antibody drug discovery," said Dr. Masamichi Koike, BioWa President and CEO. › ... › News
sorted by relevance / date